Neuroscience. Depression drugs' powers may rest on new neurons.
Vogel
Gretchen
G
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D002455:Cell Division; D003863:Depression / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D003866:Depressive Disorder / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D018450:Disease Progression; D005473:Fluoxetine / Q000494:pharmacology; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009474:Neurons / Q000502:physiology*; D011985:Receptors, Serotonin / Q000235:genetics / Q000502:physiology
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D011985:Receptors, Serotonin; D005473:Fluoxetine